Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9

Yuta Morisaki, Mamiko Niikura, Mizuho Watanabe, Kosuke Onishi, Shogo Tanabe, Yasuhiro Moriwaki, Takashi Okuda, Shinji Ohara, Shigeo Murayama, Masaki Takao, Sae Uchida, Koji Yamanaka, Hidemi Misawa

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Differential vulnerability among motor neuron (MN) subtypes is a fundamental feature of amyotrophic lateral sclerosis (ALS): fast-fatigable (FF) MNs are more vulnerable than fast fatigue-resistant (FR) or slow (S) MNs. The reason for this selective vulnerability remains enigmatic. We report here that the extracellular matrix (ECM) protein osteopontin (OPN) is selectively expressed by FR and S MNs and ALS-resistant motor pools, whereas matrix metalloproteinase-9 (MMP-9) is selectively expressed by FF MNs. OPN is secreted and accumulated as extracellular granules in ECM in three ALS mouse models and a human ALS patient. In SOD1 G93A mice, OPN/MMP-9 double positivity marks remodeled FR and S MNs destined to compensate for lost FF MNs before ultimately dying. Genetic ablation of OPN in SOD1 G93A mice delayed disease onset but then accelerated disease progression. OPN induced MMP-9 up-regulation via αvβ3 integrin in ChAT-expressing Neuro2a cells, and also induced CD44-mediated astrocyte migration and microglial phagocytosis in a non-cell-autonomous manner. Our results demonstrate that OPN expressed by FR/S MNs is involved in the second-wave neurodegeneration by up-regulating MMP-9 through αvβ3 integrin in the mouse model of ALS. The differences in OPN/MMP-9 expression profiles in MN subsets partially explain the selective MN vulnerability in ALS.

Original languageEnglish
Article number27354
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 2016 Jun 6

Fingerprint

Osteopontin
Matrix Metalloproteinase 9
Amyotrophic Lateral Sclerosis
Motor Neurons
Fatigue
Integrins
Extracellular Matrix Proteins
Phagocytosis
Astrocytes
Extracellular Matrix
Disease Progression
Up-Regulation

ASJC Scopus subject areas

  • General

Cite this

Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9. / Morisaki, Yuta; Niikura, Mamiko; Watanabe, Mizuho; Onishi, Kosuke; Tanabe, Shogo; Moriwaki, Yasuhiro; Okuda, Takashi; Ohara, Shinji; Murayama, Shigeo; Takao, Masaki; Uchida, Sae; Yamanaka, Koji; Misawa, Hidemi.

In: Scientific Reports, Vol. 6, 27354, 06.06.2016.

Research output: Contribution to journalArticle

Morisaki, Yuta ; Niikura, Mamiko ; Watanabe, Mizuho ; Onishi, Kosuke ; Tanabe, Shogo ; Moriwaki, Yasuhiro ; Okuda, Takashi ; Ohara, Shinji ; Murayama, Shigeo ; Takao, Masaki ; Uchida, Sae ; Yamanaka, Koji ; Misawa, Hidemi. / Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9. In: Scientific Reports. 2016 ; Vol. 6.
@article{b4272a5b4ee44d049f951306149de9bc,
title = "Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9",
abstract = "Differential vulnerability among motor neuron (MN) subtypes is a fundamental feature of amyotrophic lateral sclerosis (ALS): fast-fatigable (FF) MNs are more vulnerable than fast fatigue-resistant (FR) or slow (S) MNs. The reason for this selective vulnerability remains enigmatic. We report here that the extracellular matrix (ECM) protein osteopontin (OPN) is selectively expressed by FR and S MNs and ALS-resistant motor pools, whereas matrix metalloproteinase-9 (MMP-9) is selectively expressed by FF MNs. OPN is secreted and accumulated as extracellular granules in ECM in three ALS mouse models and a human ALS patient. In SOD1 G93A mice, OPN/MMP-9 double positivity marks remodeled FR and S MNs destined to compensate for lost FF MNs before ultimately dying. Genetic ablation of OPN in SOD1 G93A mice delayed disease onset but then accelerated disease progression. OPN induced MMP-9 up-regulation via αvβ3 integrin in ChAT-expressing Neuro2a cells, and also induced CD44-mediated astrocyte migration and microglial phagocytosis in a non-cell-autonomous manner. Our results demonstrate that OPN expressed by FR/S MNs is involved in the second-wave neurodegeneration by up-regulating MMP-9 through αvβ3 integrin in the mouse model of ALS. The differences in OPN/MMP-9 expression profiles in MN subsets partially explain the selective MN vulnerability in ALS.",
author = "Yuta Morisaki and Mamiko Niikura and Mizuho Watanabe and Kosuke Onishi and Shogo Tanabe and Yasuhiro Moriwaki and Takashi Okuda and Shinji Ohara and Shigeo Murayama and Masaki Takao and Sae Uchida and Koji Yamanaka and Hidemi Misawa",
year = "2016",
month = "6",
day = "6",
doi = "10.1038/srep27354",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Selective expression of osteopontin in ALS-resistant motor neurons is a critical determinant of late phase neurodegeneration mediated by matrix metalloproteinase-9

AU - Morisaki, Yuta

AU - Niikura, Mamiko

AU - Watanabe, Mizuho

AU - Onishi, Kosuke

AU - Tanabe, Shogo

AU - Moriwaki, Yasuhiro

AU - Okuda, Takashi

AU - Ohara, Shinji

AU - Murayama, Shigeo

AU - Takao, Masaki

AU - Uchida, Sae

AU - Yamanaka, Koji

AU - Misawa, Hidemi

PY - 2016/6/6

Y1 - 2016/6/6

N2 - Differential vulnerability among motor neuron (MN) subtypes is a fundamental feature of amyotrophic lateral sclerosis (ALS): fast-fatigable (FF) MNs are more vulnerable than fast fatigue-resistant (FR) or slow (S) MNs. The reason for this selective vulnerability remains enigmatic. We report here that the extracellular matrix (ECM) protein osteopontin (OPN) is selectively expressed by FR and S MNs and ALS-resistant motor pools, whereas matrix metalloproteinase-9 (MMP-9) is selectively expressed by FF MNs. OPN is secreted and accumulated as extracellular granules in ECM in three ALS mouse models and a human ALS patient. In SOD1 G93A mice, OPN/MMP-9 double positivity marks remodeled FR and S MNs destined to compensate for lost FF MNs before ultimately dying. Genetic ablation of OPN in SOD1 G93A mice delayed disease onset but then accelerated disease progression. OPN induced MMP-9 up-regulation via αvβ3 integrin in ChAT-expressing Neuro2a cells, and also induced CD44-mediated astrocyte migration and microglial phagocytosis in a non-cell-autonomous manner. Our results demonstrate that OPN expressed by FR/S MNs is involved in the second-wave neurodegeneration by up-regulating MMP-9 through αvβ3 integrin in the mouse model of ALS. The differences in OPN/MMP-9 expression profiles in MN subsets partially explain the selective MN vulnerability in ALS.

AB - Differential vulnerability among motor neuron (MN) subtypes is a fundamental feature of amyotrophic lateral sclerosis (ALS): fast-fatigable (FF) MNs are more vulnerable than fast fatigue-resistant (FR) or slow (S) MNs. The reason for this selective vulnerability remains enigmatic. We report here that the extracellular matrix (ECM) protein osteopontin (OPN) is selectively expressed by FR and S MNs and ALS-resistant motor pools, whereas matrix metalloproteinase-9 (MMP-9) is selectively expressed by FF MNs. OPN is secreted and accumulated as extracellular granules in ECM in three ALS mouse models and a human ALS patient. In SOD1 G93A mice, OPN/MMP-9 double positivity marks remodeled FR and S MNs destined to compensate for lost FF MNs before ultimately dying. Genetic ablation of OPN in SOD1 G93A mice delayed disease onset but then accelerated disease progression. OPN induced MMP-9 up-regulation via αvβ3 integrin in ChAT-expressing Neuro2a cells, and also induced CD44-mediated astrocyte migration and microglial phagocytosis in a non-cell-autonomous manner. Our results demonstrate that OPN expressed by FR/S MNs is involved in the second-wave neurodegeneration by up-regulating MMP-9 through αvβ3 integrin in the mouse model of ALS. The differences in OPN/MMP-9 expression profiles in MN subsets partially explain the selective MN vulnerability in ALS.

UR - http://www.scopus.com/inward/record.url?scp=84974784742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974784742&partnerID=8YFLogxK

U2 - 10.1038/srep27354

DO - 10.1038/srep27354

M3 - Article

C2 - 27264390

AN - SCOPUS:84974784742

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 27354

ER -